Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. 1995

P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
Division of Experimental Oncology B, Istituto Nazionale Tumori, Milan, Italy.

The cytotoxic activity of mitoxantrone and related anthracenediones has been ascribed to the ability of these compounds to interfere with DNA topoisomerase II function, resulting in DNA cleavage stimulation. The molecular details of enzyme inhibition by these intercalating agents remain to be defined. In an attempt to identify the structural determinants for optimal activity, the molecular and cellular effects of a series of heteroanalogues bearing different side-chains were examined in relation to the physico-chemical and DNA binding properties of these compounds. The results indicated that substitution of a pyridine ring for the dihydroxyphenylene ring in the planar chromophore caused a marked reduction of cytotoxic activity and of the ability to stimulate topoisomerase II-mediated DNA damage in intact cells and with simian virus 40 DNA in vitro. Although all tested derivatives were shown to intercalate into DNA, their DNA binding affinities were appreciably lower than that of mitoxantrone. The behavior of 2-aza derivatives more closely resembled that of ametantrone, suggesting that the potency of agents of this class is influenced more by the presence of hydroxyl groups than by the phenylene ring. The observation that a dramatic reduction (or loss) of the ability of aza derivatives to stimulate DNA cleavage is associated with a marked reduction of cytotoxic potency supports a primary role of topoisomerase II-mediated effects in the mechanism of action of the effective agents of this class. Because appreciable cytotoxic activity and significant in vivo antitumor efficacy are retained by compounds inactive (or poorly active) in inhibition of topoisomerase II, these results are consistent with multiple effects of anthracenediones at the cellular level.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004277 DNA, Single-Stranded A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle. Single-Stranded DNA,DNA, Single Stranded,Single Stranded DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
October 1992, Molecular pharmacology,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
July 2014, Bioorganic & medicinal chemistry letters,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
March 1994, Bulletin du cancer,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
October 1994, The Journal of biological chemistry,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
February 2014, Dalton transactions (Cambridge, England : 2003),
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
September 1995, Biochemical pharmacology,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
February 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
May 2013, Bioorganic & medicinal chemistry letters,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
May 2005, Chemico-biological interactions,
P De Isabella, and M Palumbo, and C Sissi, and G Capranico, and N Carenini, and E Menta, and A Oliva, and S Spinelli, and A P Krapcho, and F C Giuliani
January 1995, Nucleic acids research,
Copied contents to your clipboard!